EFFECTIVENESS AND SAFETY OF THE VABB TECHNIQUE UNDER ULTRASOUND GUIDANCE IN THE TREATMENT OF BENIGN BREAST TUMORS
Main Article Content
Abstract
Objectives: To investigate the complications, evaluate the initial tumor clearance efficacy, and measure patient satisfaction after treating benign breast tumors using the ultrasound-guided vacuum-assisted breast biopsy (VABB) technique under ultrasound guidance.
Patients and methods: A prospective, cross-sectional descriptive study with longitudinal follow-up was conducted on 53 patients with 64 breast tumors previously diagnosed as benign by histopathology. All patients subsequently underwent complete ultrasound-guided VABB for tumor excision and treatment at the Center for Diagnostic Imaging, Military Central Hospital 108, from May 2025 to April 2026. Post-procedural pain scores using the VAS, local complications, tumor clearance rates, and patient satisfaction levels using a 5-point Likert scale were evaluated at the 1-month follow-up.
Results: The mean age of the patients was 34.32 ± 11.38 years. The predominant histopathological diagnosis after VABB was fibroadenoma (79.69%). At the 1-month follow-up, the complete tumor clearance rate reached 95.31% per tumor and 94.34% per patient. The mean post-procedural VAS pain score was low (2.77 ± 2.09), with mild pain constituting the majority (64.15%). No severe complications were recorded; the most common complication was localized hematoma occurring in 43.75% of lesions, however, these were predominantly small hematomas (diameter < 3 cm) that were self-limiting and completely resolved after 1 month. The total rate of patients reporting satisfied and very satisfied after the intervention reached 94.34%.
Conclusions: Treating benign breast tumors using the ultrasound-guided VABB technique demonstrates high safety, minimal invasiveness, excellent initial tumor clearance, and achieves optimal patient satisfaction.
Article Details
Keywords
Benign breast tumor, vacuum-assisted breast biopsy (VABB), ultrasound, safety.
References
[2] Poudel S, Pokharel S, Khadka S. Benign breast disease among patients visiting the breast and endocrine clinic of a tertiary care centre. JNMA J Nepal Med Assoc, 2024, 62 (270): 92-94. doi: 10.31729/jnma.8426
[3] Lee S.H, Kim E.K, Kim M.J et al. Vacuum-assisted breast biopsy under ultrasonographic guidance: analysis of a 10-year experience. Ultrasonography, 2014, 33 (4): 259-266. doi: 10.14366/usg.14020
[4] Fang M, Liu G, Luo G. Feasibility and safety of image-guided vacuum-assisted breast biopsy: a PRISMA-compliant systematic review and meta-analysis of 20 000 population from 36 longitudinal studies. Int Wound J, 2019, 16 (6): 1506-1512. doi: 10.1111/iwj.13224
[5] Lê Tuấn Linh, Trương Thị Thanh. Hiệu quả và an toàn của kỹ thuật hút u vú có hỗ trợ áp lực âm dưới hướng dẫn siêu âm trong chẩn đoán và điều trị tổn thương vú lành tính. Tạp chí Y học Việt Nam, 2024, 539 (3): 363-367. doi: 10.51298/vmj.v539i3.10155
[6] Rupa R, Kushvaha S. Vacuum-assisted excision, scarless solution for fibroadenoma breast-a single-center experience. Indian J Radiol Imaging, 2021, 31 (4): 844-849. doi: 10.1055/s-0041-1735651
[7] Zouzos A, Fredriksson I, Karakatsanis A et al. Patient experience and healthcare cost aspects of vacuum-assisted excision of breast lesions: a report from the Swedish VAE randomized clinical trial. Eur J Radiol, 2025, 186: 112062. doi: 10.1016/j.ejrad.2025.112062
[8] Dong Y, Huang Y, Zhao X et al. Risk factors for hematoma formation after ultrasound-guided vacuum-assisted excision of breast fibroadenoma: an analysis based on ultrasound features. Sci Prog, 2025, 108 (2): 368504251338660. doi: 10.1177/00368504251338660
[9] Eller A, Janka R, Lux M et al. Stereotactic vacuum-assisted breast biopsy (VABB) - a patients’ survey. Anticancer Res, 2014, 34 (7): 3831-7. PMID 24982410
[10] Thurley P, Evans A, Hamilton L et al. Patient satisfaction and efficacy of vacuum-assisted excision biopsy of fibroadenomas. Clin Radiol, 2009, 64 (4): 381-5. doi: 10.1016/j.crad.2008.09.013